chrisvoncsefalvay/vaers-outcomes huggingface dataset:
feels like cold; and sweating; a lot of itchiness in his chest.; last night his arm started to hurt; had like a red Little weal ("Ronchita roja"); had an allergic reaction after taking the Tylenol:; he's having a Little bit of fever, it is almost 38°C; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (feels like cold), HYPERHIDROSIS (and sweating), PRURITUS (a lot of itchiness in his chest.), PAIN IN EXTREMITY (last night his arm started to hurt) and ERYTHEMA (had like a red Little weal ("Ronchita roja")) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING COLD (feels like cold), HYPERHIDROSIS (and sweating), PRURITUS (a lot of itchiness in his chest.), PAIN IN EXTREMITY (last night his arm started to hurt), ERYTHEMA (had like a red Little weal ("Ronchita roja")), HYPERSENSITIVITY (had an allergic reaction after taking the Tylenol:) and PYREXIA (he's having a Little bit of fever, it is almost 38°C). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency and ACETAMINOPHEN for Adverse event, at an unspecified dose and frequency. At the time of the report, FEELING COLD (feels like cold), HYPERHIDROSIS (and sweating), PRURITUS (a lot of itchiness in his chest.), PAIN IN EXTREMITY (last night his arm started to hurt), ERYTHEMA (had like a red Little weal ("Ronchita roja")), HYPERSENSITIVITY (had an allergic reaction after taking the Tylenol:) and PYREXIA (he's having a Little bit of fever, it is almost 38°C) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 38 (abnormal) Result: Patient reported little bit of fever, it is almost 38°C.         Concomitant product use was not provided by the reporter.   Treatment information provided was took Tylenol, acetaminophen, to feel better Patient reported after taking Tylenol had like a red Little weal ("Ronchita roja")
Received PPV on 5/26/10 in left deltoid- On 5/30/10 started having pain in left axilla with swelling and severe tenderness. C/O temperature on 5/31/10 up to 100.8 degrees F. Had been exercising and working out on 5/30 but not aware of trauma to arm until started hurting in evening. On observation in clinic 6/1/10 no visible swelling, redness or other local reaction noted in left deltoid area.
Information has been received from a physician concerning a male patient under the age of four years who was vaccinated wit ha dose of VARIVAX at about the age of one year. It was reported that the patient recently, "within the last three days," developed a rash. The patient also had an IGG and IGM of zero. The patient had recovered at the time of the report. The patient was seen in office. This is one of several cases from the same source. Additional information has been requested.
Large bruise at vaccine site, looked like bleeding occurred underneath the skin as if the patient was on blood thinners (review of her medication list showed Fish Oil and prednisone). Patient reported no pain at the injection site. Suggested the patient contact her doctor's office and see if they could do a telehealth appointment to look at the bruise and see if any further action was required.
Body hurt all over; Felt like she was in a dream sequence; Slept all day; Lost appetite; Got really hot; Temaparature 102 F; Fatigued; Chills; Sore arm / muscle aches; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Apr-2021 and was forwarded to Moderna on 06-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Lost appetite), PAIN (Body hurt all over), FEELING HOT (Got really hot), SOMNOLENCE (Slept all day) and ABNORMAL DREAMS (Felt like she was in a dream sequence) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CELECOXIB (CELEXA [CELECOXIB]) for an unknown indication.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 23-Apr-2021, the patient experienced MYALGIA (Sore arm / muscle aches). On 24-Apr-2021, the patient experienced DECREASED APPETITE (Lost appetite), FEELING HOT (Got really hot), PYREXIA (Temaparature 102 F), FATIGUE (Fatigued) and CHILLS (Chills). On 25-Apr-2021, the patient experienced SOMNOLENCE (Slept all day). On an unknown date, the patient experienced PAIN (Body hurt all over) and ABNORMAL DREAMS (Felt like she was in a dream sequence). At the time of the report, DECREASED APPETITE (Lost appetite), PAIN (Body hurt all over), FEELING HOT (Got really hot), SOMNOLENCE (Slept all day), ABNORMAL DREAMS (Felt like she was in a dream sequence), PYREXIA (Temaparature 102 F), FATIGUE (Fatigued), CHILLS (Chills) and MYALGIA (Sore arm / muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no treatment medication were provided   concomitants were provided
Systemic: Fainting / Unresponsive-Mild, Additional Details: Following administration patient had vasovagal syncope episode. This lasted for about 30 seconds. Patient regained full consciousness and alertness. Patient stayed in clinic room for 10 more minutes, stated he felt back to normal. He was asked to stay in the store for the next 15 minutes to ensure that this continued. Patient checked back into provider after 15 minutes and stated he had felt back to normal.
Redness and swelling of L arm from middle of upper arm to elbow. Warm to touch.
Fever, crying, erythematous papules to legs, diaper area, face, and arms
Skin infection diagnosed at Emergency on 4/30/2021. Symptoms included pain, warmth, swelling, purulent drainage per the patient. Sent home from ED with prescription for Cephalexin.
Experienced symptoms of light headedness, dizziness, nausea, room spinning, headaches. Went to doctor and was diagnosed with short term vertigo and was given anti-vert medication but symptoms still seem to persist.
Exhaustion, headache, mild fever, lymph nodes swelling in armpits, soreness
pt recvd MMR vax & devel an exacerbation of eczema; No further details were provided;
Patient had swelling/redness later on the day of the vaccine. It restricted her mobility so that she was not able to raise her arm (thereby keeping her from playing tennis). Redness continued thru Thursday and Friday. Swelling has gone down and mobility has returned to almost normal. Redness is NOT at the site of the injection--instead it is a red/blotchy area from about 3/4 the way down the humerus all the way down to the elbow and spreading  away from the side closest to the body (almost towards the BACK of the arm). It covers an area that is approximately about 7 inches by 4 inches.
Information has been received from a physician through a pregnancy registry concerning a 29 year old female pt with no previous pregnancies, no pertinent medical history  and no known allergies, who on 03-Nov-2003 was vaccinated with a first dose of varicella virus vaccine live (645297/0331N) and a second dose of varicella virus vaccine live (645297/0331N) was administered on 15-DEC-2003. The physician reported the pt's LMP was 15-Dec-2003. The physician also reported that a home and office pregnancy test was positive with the expected date of delivery reported as 20-SEP-2004. There was no treatment required. It was noted the pt did not have a local reaction at vaccination site, chicken pox or herpes zoster symptoms following vaccination. It was also noted that on 24-Sep-2003, before vaccination with varicella virus vaccine live, the pt had been tested for varicella antibodies and the results were negative. There was no product quality complaint reported. Follow-up information received from a physician reported that the pt had taken prenatal vitamins throughout her entire pregnancy as per routine and iron 325 mg TID for anemia. She had no infections or illnesses during the pregnancy. On 23-APR-2004 a routine ultrasound was normal and a maternal serum alpha-feto protein test was negative. On 24-SEP-2004 a Cesarean section was performed for breech presentation of the infant. It was noted that on 24-SEP-2004, at 40 4/7 weeks from LMP, a normal male infant weighing 9 lbs and 4 ounces was delivered via Cesarean section. The male infant had no congenital anomalies. It was noted that the infant did not have any feature of congenital varicella zoster syndrome. Unspecified medical attention was sought. No additional information is expected.
Headache , tired (slept from 4pm to next morning),low grade fever, sweat it out through out night, diarrhea I the next morning.  Got up at 10am next day feeling better.
Developed throat tightness. Client was given Benadryl 25 mg by mouth. Symptoms progressed to pain on swallowing intermittently. Started with dry productive cough without wheezing. EMS was activated. BP and Pulse taken multiple times during observation. BP 150's/80's, pulse 88 and pulse 8-20. No Hives or rashes. Client did not have further worsening of condition. Denied shortness of breath or wheezing. No swelling of the lips, tongue or oral cavity. EMS arrived and transported to hospital.
Bad headache; Nausea; Chills; Vomiting; This is a spontaneous report from a contactable consumer (patient).   A 55-year-old female patient received the 2nd dose of bnt162b2 (BNT162B2, Batch/lot # EL0140) at single dose on 16Jan2021 07:00 for Covid-19 immunisation, at healthcare facility where she worked (she worked in a kitchen, the hospital gave her the shot).  The patient medical history and concomitant medications were not reported. The patient received the 1st dose of bnt162b2 (BNT162B2, Lot # EK and maybe A or O, 231) at single dose 23Dec2020 5 o'clock for Covid-19 immunisation.  On 21Jan2021 morning the patient woke up with really bad headache, vomiting and chills. She had first the major headache and then nausea, chills and then vomited. She thought side effects happen right away. No treatment in response to event received. On 21Jan2021 she went to work.  She got the vaccine at work and then they tested her for COVID not positive in Jan2021. She also reported that on 21Jan2021 she took the COVID test and the results was unknown. The outcome of events was unknown.  Information on Lot/batch number has been requested.
Headache, Myalgia & Fever Narrative:  fever, headache, body aches for 2 days after 1st vaccine  Other Relevant History:
Patient developed fatigue shortly after vaccination.  Approximately 3-4 hours after vaccination, she developed diffuse facial swelling.  There was no dyspnea, tongue swelling, dizziness, hives, itching.  She has no history of dermal fillers or other cosmetic facial procedures.   She monitored at home, did not seek medical attention.  Swelling was resolved by the following morning when she awoke from sleep.
Developed severe headache, fever to 103 degrees and slurred speech. Seen in local ER. Abnormal lumbar puncture, no bacterial infection. Above consistent with post vaccinal encephalitis. 5/30/06 Received medical records which reveal patient experienced fever, malaise & muscle aches.  All labs & diagnostic studies were neg.  Patient was hydrated w/2L of IV fluid & d/c with no further reaction.  ER dx:  ?? vaccine reaction/ss
8:20am Tuesday: shot administered  8:30am-8:30pm Tuesday: itchy (like a rash was appearing, but never did), heightened areas of symptoms included neck, stomach  8:30pm Tuesday: onset of muscle ache  10:30pm Tuesday - 10:30pm Wednesday: severe muscle ache, unable to find comfortable resting position, lack of sleep due to pain, onset of low fever (fever ranged from 100.7 to 99.9) 12:30pm Wednesday: Fever broke and returned to normal range 10:30pm Wednesday: severe muscle aches transitioned to medium/mild muscle aches  10:30pm Wednesday-10:30am Wednesday: medium/mild muscle aches 10:30am-6:30pm Thursday: improving conditions, itchy sensation returning  10:30am Friday: all symptoms dissipated; normal state and energy levels returned As requested by paperwork for entry in Box 18: Janssen COVID-19 Vaccine EUA
Tingling/needle/itchy feeling in hands, feet, scalp, inner thighs
Light headed Hard to focus Heart pounding and racing to the point I thought I was going to pass out. It lasted two hours I did not feel normal for 4 days
No adverse events were reported.; received one improperly stored dose of PNEUMOVAX 23 on an unspecified date.; This spontaneous report has been received from a pharmacist concerning to 1 of 19 patients, a 68-year-old female patient. The patients' historical condition, concomitant medications and drug reactions or allergies were not reported.  On 21-OCT-2019, the patient was vaccinated with an improperly stored dose (product storage error) of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (dose, route and frequency were not reported) lot # S012245, the expiration date: 09-FEB-2021 for prophylaxis. The administered dose experienced a temperature excursion at lowest temperature below 36-degree Fahrenheit (32F) for 6 hours. Previous excursions were unknown by reporter. The temperature excursions were not detected by a data logger. No adverse events were reported. This is one of several reports received from the same reporter. # 1909USA001561, 2003USA005392, 2003USA005393, 2003USA005394, 2003USA005395, 2003USA005396, 2003USA005398, 2003USA005399, 2003USA005400, 2003USA005401, 2003USA005402, 2003USA005403, 2003USA005404, 2003USA005405, 2003USA005406, 2003USA005407, 2003USA005408 and 2003USA005409.  combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: Unspecified; manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S012245; expirationdate: 09-FEB-2021; deviceage and unit: 0 ; operatorofdevice: Health Care Professional; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: No; reasonfornoneval: 81 Other; reasonfornonevalother: No information about the availability; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-1909USA001561: US-009507513-2003USA005392: US-009507513-2003USA005393: US-009507513-2003USA005394: US-009507513-2003USA005395: US-009507513-2003USA005396: US-009507513-2003USA005398: US-009507513-2003USA005399: US-009507513-2003USA005400: US-009507513-2003USA005401: US-009507513-2003USA005402: US-009507513-2003USA005403: US-009507513-2003USA005404: US-009507513-2003USA005405: US-009507513-2003USA005406: US-009507513-2003USA005407: US-009507513-2003USA005408: US-009507513-2003USA005409:
Within 5 min of receiving vaccine, pt had redness at injection site. Within 1 hour of receiving vaccine, pt had redness in chest, redness in are and slight tightness in chest. Pt was given Benadryl.
0915 Generalized itching walked pt over to EMS Administered 50 mg of diphenhydramine PO
This spontaneous report was received from a other register nurse reporting an unknown number of patients of an unkonwn age and gender. Medical history and concurrent conditions were not reported. On an unknown date, the patients were vaccinated with a dose of VARIVAX (Merck) (dose, dose number, lot number, expiration date and route were not reported). Co-suspect and concomitant therapies were not reported. The nurse reported that an unknown date, an unknown number of patients were administered VARIVAX (Merck) that had been improperly stored. No adverse effects reported. This is one of three reports from the same source (MARRS 1408USA017042, 1409USA006413). Additional information has been requested.
Patient was vaccinated according to self and mother 2 weeks prior to hospitalization.  She took the first vaccine to get a job which is mandated.   11/3 Ct stroke work up. Left side weakness/decreased sensation left upper and lower, slurred speech, blurred vision nausea associated with severe headache Memory Recall difficulty    Assessment by neurologist: ? patchy decreased sensation to pinprick affecting left face and arm without particular dermatome distribution?  Labs normal except  MVP low Chloride 109 Negative tropinin
Patient's arm became swollen after getting flu shot. Doctor told patient that injection was given too high up on the arm close to the shoulders.  Patient had to take course of antibiotic treatment and got better.
SWOLLEN GLANDS INSIDE THE MOUTH, PRESSURE (PAIN) INSIDE THE MOUTH , HEADACHE FOR OVER 1 WEEK.
Pt had rec'd  Covid-19  Vaccine on  8/04/21    &   8/25/21.  She is under 18 years old, therefore should have received monovalent series, rather than a Bivalent booster.
Pt with fever on 9/4/05, then with rash on back (c/w viral exanthem). Had full septic w/u including neg CBC, neg UA, neg Blood CX, neg CSF CX, neg Urine CX. Rash gone by 9/8/05 but pt with refusal to walk/sit up. Took approx 2-3 weeks to get back to full mobility.
This is a spontaneous report from a contactable nurse practitioner communicated to a sales representative. A 92 year old female patient received a dose of PREVNAR 13 on 17Jul2017 at 0.5ml single dose for immunization. Initially the patient was fine. The patient returned to the office on 25Jul2017 and presented with a 4-6cm swollen area that was pink at the injection site. The reporter also said that along the edge of the swollen area there was a rash. The reaction occurred 8 days after receiving the injection. The outcome of the event was unknown.
Sore muscles; Aching joints; Congestion; Sore back; Fever (101.8 was the highest reading); Constant tiredness; Inability to sleep at night; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0158) via an unspecified route of administration in the left arm  on 21Apr2021 at 20:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8737) via an unspecified route of administration in the left arm on 31Mar2021 at 19:30 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. On 22Apr2021 at 09:00, the patient experienced sore muscles, aching joints, congestion, sore back, fever (101.8 was the highest reading), constant tiredness and inability to sleep at night. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events sore muscles, aching joints, congestion, sore back, fever (101.8 was the highest reading), constant tiredness and inability to sleep at night were resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
At 11:15 am, I started to feel really tired and have body aches. Within the hour, I had a fever of 100.9, achier body, headache, no appetite, sore neck and very tired. This lasted until 2 am (when my fever broke through the night a couple of times).  For the rest of the day on Sunday, I did not have a fever but was still tired. By Monday I had no aches, no fever and not tired anymore.
shot received wen am, trouble breathing and cough developed wen evening.  itchy eyes on friday, hives and facial swelling on sat.  cough and shortness of breath continues despite cough meds, nebulizer tx when seen in the office on Mon
Pt felt aches and tired evening after  her 10am vaccine and did not sleep much that night. Awoke nauseated and tried to get ready for work and had single  syncopal episode with LOC about 10-15 seconds.  Her symptoms all improved over the next few minutes.  She did a telehealth visit with me a couple hours after.  No further treatment was rendered.
Arm soreness; By mistake we gave an expired Moderna vaccine to a patient today; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) and EXPIRED PRODUCT ADMINISTERED (By mistake we gave an expired Moderna vaccine to a patient today) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (By mistake we gave an expired Moderna vaccine to a patient today). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm soreness). On 09-May-2021, EXPIRED PRODUCT ADMINISTERED (By mistake we gave an expired Moderna vaccine to a patient today) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm soreness) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   No treatment information was provided. ?It was reported that the patient took his second dose of Moderna COID-19 vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: New event, arm soreness was added and I narrative was updated.
Information has been received from a registered nurse concerning a 21 week old female who on 07-FEB-2008, 19-May-2008 and 23-May-2008 was vaccinated po with the first, second and third doses respectively of ROTATEQ (659854/0217X second dose ) (660380/0277X third dose). It was reported that on 19-MAY-2008 and 23-May-2008 the patient vomited after the vaccine was given. No other symptoms were reported. It was reported that the patient recovered. Additional information has been requested.
After the vaccination, I went to the ER. They said they weren't finding anything wrong with me. My blood pressure was high and my heart was beating very fast. I was there several hours for them to watch me. They did blood tests and they did an x-ray of my lungs. They released me because my condition wasn't getting any worse, and my numbers went down a little bit. They sent me home to take a benadryl and go to bed. They also said my symptoms could be related to an anxiety attack after being home for a year alone with my cat and then going out into the public. When I went home and took the benadryl and went to bed, I felt fine the next day.